Comparison between different first-line therapy protocols in eradicating Helicobacter pylori in a region with high clarithromycin resistance

摘要

IntroductionHelicobacter pylori infection is encountered in more than 50% of the world population. A high rate of clarithromycin resistance is observed among Helicobacter pylori strains in some regions because clarithromycin is a drug commonly used for the treatment of other infections.